Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACTIVE Dialysis - A Multicentre, Unblinded, Randomised, Controlled Trial to Assess Quality of Life, Clinical Outcomes and Cost Utility for Extended vs Standard Duration of Dialysis in Patients With End Stage Kidney Disease.

NCT00649298 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT00649298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00649298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACTIVE Dialysis - A Multicentre, Unblinded, Randomised, Controlled Trial to Assess Quality of Life, Clinical Outcomes and Cost Utility for Extended vs Standard Duration of Dialysis in Patients With End Stage Kidney Disease.
Lead sponsor
The George Institute
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
October 31, 2014
Enrollment
200 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

end stage kidney disease, end stage renal disease, renal dialysis, renal replacement therapy, uremia